Promotion of iga immune response in patients with crohn's disease by oral bacteriotherapy with lactobacillus gg

Annals of Nutrition and Metabolism

Volumn 40, Issue 3, 1996, Pages 137-145

  Malin, Merja ^a,b   Suomalainen, Hanna ^b   Saxelin, Maija ^c   Isolauri, Erika ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c VALIO LTD   (Finland)

Author keywords

Crohn's disease; Juvenile chronic arthritis; Lactobacillus

Indexed keywords

BETA LACTOGLOBULIN; CASEIN; IMMUNOGLOBULIN A;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; INTESTINE MUCOSA; JUVENILE RHEUMATOID ARTHRITIS; LACTOBACILLUS CASEI; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; CASEINS; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; DIGESTIVE SYSTEM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FINLAND; HUMANS; IMMUNOGLOBULIN A; LACTOBACILLUS; LACTOGLOBULINS; MALE;

LACTOBACILLUS; LACTOBACILLUS CASEI;

EID: 0029790416     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000177907     Document Type: Article

References (37)

1. Price AB: The pathology; in Jáme-roth G, Lennard-Jones J. Truclove S (cds); Inflammatory Bowel Disease. Malmo. Grafiska Publishing. 1992. pp 269-293.
2. Baklicn K, Brandzaeg P: Immunohistochemical characterization oflo-cal immunoglobulin formation in Crohn's disease of the ileum. Scand J Gastroenterol 1976; 11:447-457.
3. MacDermott RP; Altered secretion patterns of IgA and IgG subclasses by IBD intestinal mononuclear cells: in Goebell H, Peskas BM (eds): Inflammatory Bowel Disease: Basic Research and Clinical Implications. Lancaster, MTP Press, 1988, pp 105-111.
4. Brandzaeg P. Halstenscn TS. Rett K, Krajci P, Kvale D, Rognum TO, Scott H, Sollid LM: Immunobiology and immunopathology of human gut mucosa: Humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989:97:1562-1584.
5. Olaison G, Sjodahl R., Tagesson C: Abnormal intestinal permeability in Crohn’s disease: A possible pathogenic factor. Scand J Gastroenterol 1990:25:321-328.
6. O’Morain C, Segal AW., Levi AJ: Elemental diet as primary treatment of acute Crohn's disease: A controlled trial. Br Med J 1984:288: 1859-1862.
7. Workman EM, Alun Jones V, Wilson AJ, Hunter JO: Diet in the management of Crohn's disease. Hum Nutr 1984;38A:469-473.
8. Harper PH. Lee ECG, Kcttlewcll MGW, Bennett MK. Jewell DP: Role of the faecal stream in the maintenance of Crohn’s colitis. Gut 1985:26:279-284.
9. Ruuska T, Savilahti E, Maki M, Or-mâlâ T, Visakorpi J: Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 1994: 19:175-180.
10. Rooney PJ. Jenkins RT. Buchanan WW: A short review of the relationship between intestinal permeability and inflammatory joint disease. Clin Exp Rheumatol 1990;8:75-83.
11. Savage DC: Interactions between the host and its microbes; in Clarke R (ed): Microbial Ecology of the Gut. New York. Academic Press, 1977. pp 277-310.
12. Perdigón G. Alvarez S. de Macias MAN, Roux ME, de Ruiz Holgado AP: The oral administration of lactic acid bacteria increases the mucosal intestinal immunity in response to enteropathogens. J Food Protect 1990:53:404-410.
13. Kaila M., Isolauri E, Soppi E., Virta-nen E., Laine S. , Arvilommi H: Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992;32: 141-144.
14. Isolauri E, Majamaa H. Arvola T. Rantala I, Virtanen E., Arvilommi H: Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993: 105:1643-1650.
15. Millar MR., Bacon C, Smith SL., Walker V., Hall MA: Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child 1993:69: 483-487.
16. Donohue DC., Deighton M, Ahokas J., Salminen S: Toxicity of lactic acid bacteria; in Salminen S, von Wright A (eds): Lactic Acid Bacteria. New York. Dekker. 1993, pp 307-313.
17. Hvams JS., Ferry GD., Mandel FS., Gryboski JD., Kibort PM., Kirschner BS., Griffiths AM, Katz AJ., Grand RJ., Boyle JT., Michencr WM., Levy JS, Lesser ML: Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991:12:439- 447.
18. Wood PH: Nomenclature and classification of arthritis in children: in Munthe E (cd): The Care of Rheumatic Children. Basel, Eular Publishing, 1978, pp 47-50.
19. Kantele A. Arvilommi H. Jokinen I: Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis 1986:158:1126-1131.
20. Forrest BD: Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet 1988;vol i:81-83.
21. Isolauri E, Virtanen E., Jalonen T., Arvilommi H: Local immune response measured in blood lymphocytes reflects the clinical reactivity of children with cow's milk allergy. Pediatr Res 1990:28:582-586.
22. Gardner MJ. Altman DG: Statistics with Confidence: Confidence Intervals and Statistical Guidelines. London. British Medical Journal, 1989.
23. Goldin BR., Gorbach SL, Saxclin M., Barakat S., Gualtieri L, Salminen S: Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992;37:121- 128.
24. Walker WA: Mechanisms of antigen handling by the gut. Clin Immunol Allergy 1982;2:15-40.
25. Suomalainen H. Isolauri E, Kaila M. Virtanen E, Arvilommi H: Cow's milk provocation induces an immune response to unrelated dietary' antigens. Gut 1992;33:1179-1183.
26. Marcolongo R, Bayeli PF, Montag-nani M: Gastrointestinal involvement in rheumatoid arthritis: A biopsy study. J Rheumatol 1979:6: 163-173.
27. Shinebaum R. Neumann VC, Cooke EM, Wright V: Comparison of faecal florae in patients with rheumatoid arthritis and controls. Br J Rheumatol 1987:26:329-333.
28. O'Farrelly C, Marten D, Melcher D, McDougall B., Price R., Goldstein AJ, Sherwood R., Fernandes L: Association between villous atrophy in rheumatoid arthritis and a rheumatoid factor and gliadin-spcciftc IgG. Lancet 1988:vol ii:819-822.
29. Koot VCM, Van Straaten M. Hck-kens WTh MJ., Collee G, Dijkmans BAC: Elevated level of IgA gliadin antibodies in patients with rheumatoid arthritis. Clin Exp Rheumatol 1989;7:623-626.
30. Pellegrini G. Scotta MS, Soardo S, Avanzini MA, Ravelli A, Burgio GR, Martini A: Elevated IgA anti-gliadin antibodies in juvenile chronic arthritis. Clin Exp Rheumatol 1991:9:653-656.
31. Bjarnason I., So A., Levi AJ, Peters TJ, Williams P., Zanelli GD., Gum-pel JM, Ansell B: Intestinal permeability and inflammation in rheumatoid arthritis: Effects of non-steroidal anti-inflammatory drugs. Lancet 1984; vol ii:1171-1173.
32. Jenkins RT., Rooney PJ., Jones DB., Bienenstock J, Goodcare RL: Increased intestinal permeability in patients with rheumatoid arthritis: A side effect of oral nonsteroidal anti-inflammatory drug therapy? Br J Rheumatol 1987;26:103-107.
33. Buchanan HM. Preston SJ. Brooks PM. Buchanan WW: Is diet important in rheumatoid arthritis? Br J Rheumatol 1991:30:125-134.
34. Weltzin R., Lucia-Jandris P., Michetti P., Fields BN, Krahenbühl JP., Ncutra MR: Binding and transepi-thelial transport of immunoglobulins by intestinal M cells: Demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol 1989;108:1673-1685.
35. Doe WF: The intestinal immune system. Gut 1989;30:1679-1685.
36. Elo S. Saxelin M. Salminen S: Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2: Comparison with other dairy strains. Lett Appl Microbiol 1991;13:154-156.
37. Saxelin M, Elo S, Salminen S, Va-paatalo H: Dose-response colonisation of faeces after oral administration of Lactobacillus casei strain GG. Microbial Ecol Health Dis 1991;4:209-214.